Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TEL/AML1 and immunoreceptor gene rearrangements-which comes first?
Zuna J, Krejci O, Madzo J, Fronkova E, Sramkova L, Hrusak O, Kalina T, Vaskova M, Stary J, Trka J; Czech Paediatric Haematology Working Group (CPH). Zuna J, et al. Among authors: hrusak o. Leuk Res. 2005 Jun;29(6):633-9. doi: 10.1016/j.leukres.2004.11.007. Epub 2005 Jan 18. Leuk Res. 2005. PMID: 15863202
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry.
Trka J, Kalinová M, Hrusák O, Zuna J, Krejcí O, Madzo J, Sedlácek P, Vávra V, Michalová K, Jarosová M, Starý J; For Czech Paediatric Haematology Working Group. Trka J, et al. Among authors: hrusak o. Leukemia. 2002 Jul;16(7):1381-9. doi: 10.1038/sj.leu.2402512. Leukemia. 2002. PMID: 12094264
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Fronkova E, Mejstrikova E, Avigad S, Chik KW, Castillo L, Manor S, Reznickova L, Valova T, Zdrahalova K, Hrusak O, Jabali Y, Schrappe M, Conter V, Izraeli S, Li CK, Stark B, Stary J, Trka J. Fronkova E, et al. Among authors: hrusak o. Leukemia. 2008 May;22(5):989-97. doi: 10.1038/leu.2008.22. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305563 Clinical Trial.
Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment.
Vakrmanova B, Fronkova E, Zuna J, Janotova I, Jabali Y, Rezkova Reznickova L, Zdrahalova K, Trka J, Stary J, Hrusak O, Mejstrikova E. Vakrmanova B, et al. Among authors: hrusak o. Leuk Lymphoma. 2021 Mar;62(3):752-754. doi: 10.1080/10428194.2020.1839659. Epub 2020 Oct 29. Leuk Lymphoma. 2021. PMID: 33118409 No abstract available.
113 results